Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20-24 weeks' gestation - PubMed
Review
Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20-24 weeks' gestation
Justin T Diedrich et al. Contraception. 2020 May.
Abstract
Although only 1.3% of abortions in the United States are between 20 and 24 weeks' gestation, these procedures are associated with elevated risks of morbidity and mortality. Adequate cervical preparation before dilation and evacuation (D&E) at 20-24 weeks' gestation reduces procedural risk. For this gestational range, at least one day of cervical preparation with osmotic dilators is recommended before D&E. The use of overnight osmotic dilators alone is sufficient for most D&Es at 20-24 weeks' gestation. Dilapan-S® dilators require a shorter time to achieve maximum dilation, may be more effective than laminaria and may increase the likelihood of success on the first D&E attempt. The use of adjunctive mifepristone administered one-day pre-operatively at the time of osmotic dilator placement, should be considered because evidence demonstrates that it makes D&E subjectively easier at 20-24 weeks without increasing side effects. While older studies suggest that two-days of serial osmotic dilators provide greater dilation than one day of dilators, adjunctive mifepristone may be comparable to a second day of dilators. Adjunctive misoprostol administered on the day of D&E does not appear to affect initial cervical dilation and procedure time and compared with mifepristone is associated with more side effects, such as pain and nausea. Using overnight mifepristone and same-day misoprostol without osmotic dilators at 20-24 weeks' gestation lengthens D&E procedure time and appears to increase immediate complications, at least among less experienced providers. Some evidence shows the feasibility of same-day cervical preparation before D&E at 20-24 weeks using Dilapan-S® with adjunctive misoprostol or serial repeat dosing of misoprostol, but same-day preparation should be limited to providers with significant experience with these regimens. The Society of Family Planning recommends preoperative cervical preparation before D&E at 20-24 weeks' gestation. Further studies are needed to clarify the best means of preparing the cervix in order to minimize abortion complications and improve outcomes in this gestational range.
Keywords: Abortion; Cervical preparation; Dilation; Dilation & evacuation; Mifepristone; Misoprostol; Second-trimester.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Cervical preparation for second trimester dilation and evacuation.
Newmann SJ, Dalve-Endres A, Diedrich JT, Steinauer JE, Meckstroth K, Drey EA. Newmann SJ, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007310. doi: 10.1002/14651858.CD007310.pub2. Cochrane Database Syst Rev. 2010. PMID: 20687085 Review.
-
Fox MC, Krajewski CM. Fox MC, et al. Contraception. 2014 Feb;89(2):75-84. doi: 10.1016/j.contraception.2013.11.001. Epub 2013 Nov 11. Contraception. 2014. PMID: 24331860
-
Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation.
Fox MC, Hayes JL; Society of Family Planning. Fox MC, et al. Contraception. 2007 Dec;76(6):486-95. doi: 10.1016/j.contraception.2007.09.004. Epub 2007 Nov 9. Contraception. 2007. PMID: 18061709
-
Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation.
Newmann S, Dalve-Endres A, Drey EA; Society of Family Planning. Newmann S, et al. Contraception. 2008 Apr;77(4):308-14. doi: 10.1016/j.contraception.2008.01.004. Epub 2008 Mar 4. Contraception. 2008. PMID: 18342657
-
O'Shea LE, Lohr PA, Lord J, Hasler E, Cameron S. O'Shea LE, et al. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100283. doi: 10.1016/j.ajogmf.2020.100283. Epub 2020 Nov 28. Am J Obstet Gynecol MFM. 2021. PMID: 33451604 Review.
Cited by
-
The hormonal control of parturition.
Hamburg-Shields E, Mesiano S. Hamburg-Shields E, et al. Physiol Rev. 2024 Jul 1;104(3):1121-1145. doi: 10.1152/physrev.00019.2023. Epub 2024 Feb 8. Physiol Rev. 2024. PMID: 38329421 Review.
-
Kehl S, Hösli I, Pecks U, Reif P, Schild RL, Schmidt M, Schmitz D, Schwarz C, Surbek D, Abou-Dakn M. Kehl S, et al. Geburtshilfe Frauenheilkd. 2021 Aug;81(8):870-895. doi: 10.1055/a-1519-7713. Epub 2021 Aug 9. Geburtshilfe Frauenheilkd. 2021. PMID: 34393254 Free PMC article.
-
Socha MW, Flis W, Wartęga M, Kunicka A, Stankiewicz M. Socha MW, et al. Med Sci Monit. 2023 Jun 27;29:e940127. doi: 10.12659/MSM.940127. Med Sci Monit. 2023. PMID: 37368878 Free PMC article. Review.
-
Dzuba IG, Chandrasekaran S, Fix L, Blanchard K, King E. Dzuba IG, et al. Womens Health Rep (New Rochelle). 2022 May 12;3(1):533-542. doi: 10.1089/whr.2021.0103. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 35651992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical